Status:
UNKNOWN
SHMT1 Polymorphism in Parkinson's Disease,
Lead Sponsor:
Assiut University
Collaborating Sponsors:
Aswan University Hospital
Conditions:
Study the Role of SHMT1 Polymorphism in Parkinson Disease
Eligibility:
All Genders
50+ years
Brief Summary
Parkinson Disease (PD) is the most common movement disorder and represents the second most common degenerative disease of the central nervous system . SHMT has been shown to be associated with various...
Detailed Description
This case -control observational prospective study will conducted on 40 patients with PD.
Eligibility Criteria
Inclusion
- Patients age ≥ 50 years.
- Patients with PD diagnosed according to the United Kingdom Parkinson's Disease Society Brain Bank (UK PDS Brain Bank diagnostic criteria)
Exclusion
- Patients with parkinsonian plus syndrome
- Patients with secondary parkinsonism
- Patients with other chronic comorbidities (renal, hepatic, and endocrinal disturbances and chronic chest disease.)
- Past and /or present history of epilepsy.
- Patients with disturbed conscious level.
Key Trial Info
Start Date :
January 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04706065
Start Date
January 31 2021
End Date
January 1 2022
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Effat abdelhady tony
Asyut, Egypt, 71515